Literature DB >> 24044036

Regulation of GABAA receptors by fragile X mental retardation protein.

Baosong Liu1, Lijun Li, Juan Chen, Zefen Wang, Zhiqiang Li, Qi Wan.   

Abstract

Fragile X syndrome (FXS) is caused by the loss of fragile X mental retardation protein (FMRP). The deficiency of GABAA receptors (GABAARs) is implicated in FXS. However, the underlying mechanisms remain unclear. To investigate the effect of FMRP on GABAARs, we transfected FMRP cDNAs in rat cortical neurons. We measured the protein expression of GABAARs and phosphatase PTEN, and recorded GABAAR-mediated whole-cell currents in the transfected neurons. We show that the transfection of FMRP cDNAs causes increased protein expression of GABAARs in cortical neurons, but GABAAR-mediated whole-cell currents are not potentiated by FMRP transfection. These results suggest the possibility that intracellular signaling antagonizing GABAAR activity may play a role in inhibiting GABAAR function in FMRP-transfected neurons. We further show that FMRP transfection results in an enhanced protein expression of PTEN, which contributes to the inhibition of GABAAR function in FMRP-transfected neurons. These results indicate that GABAARs are regulated by FMRP through both an up-regulation of GABAAR expression and a PTEN enhancement-induced inhibition of GABAAR function, suggesting that an abnormal regulation of GABAAR and PTEN by the loss of FMRP underlies the pathogenesis of FXS.

Entities:  

Keywords:  Fragile X syndrome; GABAA receptor; PTEN; fragile X mental retardation protein

Year:  2013        PMID: 24044036      PMCID: PMC3773076     

Source DB:  PubMed          Journal:  Int J Physiol Pathophysiol Pharmacol        ISSN: 1944-8171


  34 in total

1.  Regulation of AMPA receptor endocytosis by a signaling mechanism shared with LTD.

Authors:  E C Beattie; R C Carroll; X Yu; W Morishita; H Yasuda; M von Zastrow; R C Malenka
Journal:  Nat Neurosci       Date:  2000-12       Impact factor: 24.884

2.  Internalization of ionotropic glutamate receptors in response to mGluR activation.

Authors:  E M Snyder; B D Philpot; K M Huber; X Dong; J R Fallon; M F Bear
Journal:  Nat Neurosci       Date:  2001-11       Impact factor: 24.884

Review 3.  The fragile X syndrome: exploring its molecular basis and seeking a treatment.

Authors:  Barbara Bardoni; Laetitia Davidovic; Mounia Bensaid; Edouard W Khandjian
Journal:  Expert Rev Mol Med       Date:  2006-04-21       Impact factor: 5.600

Review 4.  Multiple roles of protein kinases in the modulation of gamma-aminobutyric acid(A) receptor function and cell surface expression.

Authors:  Nicholas Brandon; Jasmina Jovanovic; Stephen Moss
Journal:  Pharmacol Ther       Date:  2002 Apr-May       Impact factor: 12.310

Review 5.  Fragile X syndrome: loss of local mRNA regulation alters synaptic development and function.

Authors:  Gary J Bassell; Stephen T Warren
Journal:  Neuron       Date:  2008-10-23       Impact factor: 17.173

6.  Preservation of GABAA receptor function by PTEN inhibition protects against neuronal death in ischemic stroke.

Authors:  Baosong Liu; Lijun Li; Quanguang Zhang; Ning Chang; Dianshi Wang; Yuexin Shan; Lei Li; Hanbin Wang; Hua Feng; Liang Zhang; Darrell W Brann; Qi Wan
Journal:  Stroke       Date:  2010-04-01       Impact factor: 7.914

7.  Epilepsy and EEG findings in males with fragile X syndrome.

Authors:  S A Musumeci; R J Hagerman; R Ferri; P Bosco; B Dalla Bernardina; C A Tassinari; G B De Sarro; M Elia
Journal:  Epilepsia       Date:  1999-08       Impact factor: 5.864

8.  Expression of the GABAergic system in animal models for fragile X syndrome and fragile X associated tremor/ataxia syndrome (FXTAS).

Authors:  Charlotte D'Hulst; Inge Heulens; Judith R Brouwer; Rob Willemsen; Natalie De Geest; Simon P Reeve; Peter P De Deyn; Bassem A Hassan; R Frank Kooy
Journal:  Brain Res       Date:  2008-12-03       Impact factor: 3.252

9.  Age- and region-specific imbalances of basal amino acids and monoamine metabolism in limbic regions of female Fmr1 knock-out mice.

Authors:  Michael Gruss; Katharina Braun
Journal:  Neurochem Int       Date:  2004-07       Impact factor: 3.921

10.  Decreased GABA(A) receptor expression in the seizure-prone fragile X mouse.

Authors:  Abdeslem El Idrissi; Xiao-Hua Ding; Jason Scalia; Ekkhart Trenkner; W Ted Brown; Carl Dobkin
Journal:  Neurosci Lett       Date:  2004-12-23       Impact factor: 3.046

View more
  7 in total

1.  Deficient Sleep in Mouse Models of Fragile X Syndrome.

Authors:  R Michelle Saré; Lee Harkless; Merlin Levine; Anita Torossian; Carrie A Sheeler; Carolyn B Smith
Journal:  Front Mol Neurosci       Date:  2017-09-01       Impact factor: 5.639

2.  ERK 1/2 Activation Mediates the Neuroprotective Effect of BpV(pic) in Focal Cerebral Ischemia-Reperfusion Injury.

Authors:  Rui Liu; Jun-Chun Tang; Meng-Xian Pan; Yang Zhuang; Ya Zhang; Hua-Bao Liao; Dan Zhao; Yang Lei; Rui-Xue Lei; Shu Wang; An-Chun Liu; Xing-Ping Qin; Juan Chen; Zhi-Feng Zhang; Qi Wan
Journal:  Neurochem Res       Date:  2018-06-07       Impact factor: 3.996

Review 3.  Sensory Processing Phenotypes in Fragile X Syndrome.

Authors:  Maham Rais; Devin K Binder; Khaleel A Razak; Iryna M Ethell
Journal:  ASN Neuro       Date:  2018 Jan-Dec       Impact factor: 4.146

Review 4.  Impaired GABA Neural Circuits Are Critical for Fragile X Syndrome.

Authors:  Fei Gao; Lijun Qi; Zhongzhen Yang; Tao Yang; Yan Zhang; Hui Xu; Huan Zhao
Journal:  Neural Plast       Date:  2018-10-03       Impact factor: 3.599

Review 5.  Impaired activity-dependent neural circuit assembly and refinement in autism spectrum disorder genetic models.

Authors:  Caleb A Doll; Kendal Broadie
Journal:  Front Cell Neurosci       Date:  2014-02-07       Impact factor: 5.505

Review 6.  The contribution of inhibitory interneurons to circuit dysfunction in Fragile X Syndrome.

Authors:  Christian A Cea-Del Rio; Molly M Huntsman
Journal:  Front Cell Neurosci       Date:  2014-08-25       Impact factor: 5.505

Review 7.  Modeling Fragile X Syndrome Using Human Pluripotent Stem Cells.

Authors:  Hagar Mor-Shaked; Rachel Eiges
Journal:  Genes (Basel)       Date:  2016-09-28       Impact factor: 4.096

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.